Overview

Glutathione (GSH) In The Treatment of Parkinson's Disease

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This is an investigator initiated pilot study to examine the effects of GSH in PD. The goal of this study is to acquire some basic data regarding side effects and efficacy of this compound to determine if this is a possible treatment option that could be recommended to interested PD patients.
Phase:
Phase 2
Details
Lead Sponsor:
University of South Florida
Collaborator:
Wellness Health & Pharmaceuticals, Inc.